Drug interactions, side effects and safety considerations

Warning
For full list of warnings, drug interactions & side effects please refer to drug-specific sections of the or .

Tetracyclines

(e.g. doxycycline, oxytetracycline, lymecycline)

  • Avoid in pregnancy and in those under 12 years old - can cause permanent tooth discolouration and enamel hypoplasia
  • Reduced absorption (up to 100%) with iron, calcium, magnesium and some nutritional supplements
  • Photosensitivity may occur - advise patients to avoid exposure to sunlight/sun lamps

 


Quinolones

(e.g. ciprofloxacin, ofloxacin, levofloxacin) 

Note: MHRA safety advice

Only to be considered in situations where there are contraindications, resistance, side effects or treatment failure to 1st line antibiotics

Patient information leaflet required on prescription

Key safety considerations are summarised in this NHS D&G Quinolone safety alert poster

  • Higher risk of tendon injury in over 60 years old, renally impaired, solid-organ transplant
  • High risk for serious drug interactions (see the BNF or seek pharmacy advice)
  • Avoid in patients with a prolonged QTc interval
  • Avoid prescribing in combination with corticosteroids
  • Reduced absorption with iron, calcium, magnesium and some nutritional supplements
  • Stop treatment at the first sign of side effects (tendonitis)

 


Metronidazole

  • Alcohol must be avoided completely whilst taking metronidazole and for 48 hours after stopping treatment

 


Macrolides

(e.g clarithromycin, erythromycin, azithromycin)

  • High risk for serious drug interactions (see the BNF or seek pharmacy advice)
  • Avoid in patients with a prolonged QTc interval
  • Avoid Clarithromycin and Erythromycin with statins (omit statin for duration of course)

 


Trimethoprim / Co-trimoxazole

Avoid concomitant use with Methotrexate - can cause severe (potentially fatal) bone marrow suppression

 


Cephalosporins

(e.g. cefalexin, cefaclor)

  • See User Guide section on penicillin allergy and cross-sensitivity with other beta-lactam antibiotics

Editorial Information

Last reviewed: 31/07/2024

Next review date: 31/07/2027

Version: V.1.0

Approved By: AMT (23.07.24) and ADTC (31.07.24)

Reviewer name(s): Jon van Aartsen (consultant microbiologist), Claire Mitchell (pharmacist).